Cercar
01/11/2022
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
Krajewski, W, Aumatell, J, Subiela, JD, Nowak, L, Tukiendorf, A, Moschini, M, Basile, G, Poletajew, S, Malkiewicz, B, Del Giudice, F, Maggi, M, Chung, BI, Cimadamore, A, Galosi, AB, Delle Fave, RF, D'Andrea, D, Shariat, SF, Hornak, J, Babjuk, M, Chorbinska, J, Teoh, JYC, Muilwijk, T, Joniau, S, Tafuri, A, Antonelli, A, Panunzio, A, Alvarez-Maestro, M, Simone, G, Mastroianni, R, Laszkiewicz, J, Lonati, C, Zamboni, S, Simeone, C, Niedziela, L, Candela, L, Macek, P, Contieri, R, Hidalgo, BG, Rivas, JG, Sosnowski, R, Mori, K, Mir, C, Soria, F, Gonzalez-Padilla, DA, Faba, OR, Palou, J, Ploussard, G, Rajwa, P, Halon, A, Laukhtina, E, Pradere, B, Tully, K, Burgos, FJ, Cidre, MAJ, Szydelko, T. Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2022; 40(11)DOI:10.1016/j.urolonc.2022.06.008. PMID:35851185. IF:2.700(Q2/5D).
01/11/2022
Multicenter comparative study of open, laparoscopic, and robotic pyeloplasty in the pediatric population for the treatment of ureteropelvic junction obstruction (UPJO)
Gonzalez, ST, Rosito, TE, Tur, AB, Ruiz, J, Gozalbez, R, Maiolo, A, Tavares, PM, Gorgen, ARH, de Kencht, EL, Madarriaga, YQ, Weller, S, Tobia, IP, Castellan, M, Corbetta, JP. Multicenter comparative study of open, laparoscopic, and robotic pyeloplasty in the pediatric population for the treatment of ureteropelvic junction obstruction (UPJO). International Braz J Urol. 2022; 48(6)DOI:10.1590/S1677-5538.IBJU.2022.0194. PMID:36083265. IF:3.700(Q1/3D).
21/10/2022
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study
Bonfill, X, Martinez-Zapata, MJ, Barrionuevo-Rosas, L, Vernooij, RWM, Sanchez, MJ, Morales-Suarez-Varela, M, De la Cruz, J, Emparanza, JI, Ferrer, M, Pijoan, JI, Palou, J, Frances, A, Madrid, E, Coscia, C, Zamora, J. Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study. MEDICINE. 2022; 101(42)DOI:10.1097/MD.0000000000031175. PMID:36281169. IF:1.600(Q3/8D).
04/10/2022
How Reliable Is Endoscopic Stone Recognition? A Comparison Between Visual Stone Identification and Formal Stone Analysis
Henderickx, MMEL, Stoots, SJM, De Bruin, DM, Wijkstra, H, Freund, JE, Wiseman, OJ, Ploumidis, A, Skolarikos, A, Somani, BK, Sener, TE, Emiliani, E, Dragos, LB, Villa, L, Talso, M, Daudon, M, Traxer, O, Kronenberg, P, Doizi, S, Tailly, T, Tefik, T, Hendriks, N, Beerlage, HP, Baard, J, Kamphuis, GM. How Reliable Is Endoscopic Stone Recognition? A Comparison Between Visual Stone Identification and Formal Stone Analysis. JOURNAL OF ENDOUROLOGY. 2022; 36(10)DOI:10.1089/end.2022.0217. PMID:35651279. IF:2.700(Q2/5D).
01/10/2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
Tan, WS, Steinberg, G, Witjes, JA, Li, R, Shariat, SF, Roupret, M, Babjuk, M, Bivalacqua, TJ, Psutka, SP, Williams, SB, Cookson, MS, Palou, J, Kamat, AM. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. European Urology Oncology. 2022; 5(5)DOI:10.1016/j.euo.2022.05.005. PMID:35718695. IF:8.200(Q1/1D).
01/10/2022
Three-dimensional Augmented Reality-guided Robotic-assisted Kidney Transplantation: Breaking the Limit of Atheromatic Plaques
Piana, A, Gallioli, A, Amparore, D, Diana, P, Territo, A, Campi, R, Gaya, JM, Guirado, L, Checcucci, E, Bellin, A, Palou, J, Serni, S, Porpiglia, F, Breda, A. Three-dimensional Augmented Reality-guided Robotic-assisted Kidney Transplantation: Breaking the Limit of Atheromatic Plaques. EUROPEAN UROLOGY. 2022; 82(4)DOI:10.1016/j.eururo.2022.07.003. PMID:35985902. IF:23.400(Q1/1D).